GH Research Announces Publication of Phase 2b Results for Mebufotenin in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
Questcorp Mining and Riverside Resources Commence Phase 2 Exploration Program at the La Union Project, Sonora, Mexico
Alvopetro Announces Additional Firm Gas Sales, Updated Natural Gas Pricing & Q1 2026 Record Production
